Literature DB >> 11997

Further evidence implicating E-type prostaglandins in the patency of the lamb ductus arteriosus.

P M Olley, E Bodach, J Heaton, F Coceani.   

Abstract

A blocker of prostaglandin (PG) snythesis, indomethacin, given to pregnant ewes near term produces constriction of the lamb ductus arteriosus in utero. The result supports the hypothesis formulated previously that E-type prostaglandins, which are potent relaxant on the ductus, are responsible for maintaining the patency of the vessel during foetal life.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 11997     DOI: 10.1016/0014-2999(75)90248-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

Review 1.  Patent ductus arteriousus in the premature neonate: current concepts in pharmacological management.

Authors:  C Hammerman; M Kaplan
Journal:  Paediatr Drugs       Date:  1999 Apr-Jun       Impact factor: 3.022

Review 2.  Patent ductus arteriosus: experimental aspects.

Authors:  J C Mott
Journal:  Arch Dis Child       Date:  1980-02       Impact factor: 3.791

3.  The prostaglandin challenge. Test to unmask obstructed total anomalous pulmonary venous connections in asplenia syndrome.

Authors:  R M Freedom; P M Olley; F Coceani; R D Rowe
Journal:  Br Heart J       Date:  1978-01

4.  Indomethacin promotes nitric oxide function in the ductus arteriosus in the mouse.

Authors:  D Sodini; B Baragatti; S Barogi; V E Laubach; F Coceani
Journal:  Br J Pharmacol       Date:  2008-02-25       Impact factor: 8.739

5.  Prostaglandins, ductus arteriosus, pulmonary circulation: current concepts and clinical potential.

Authors:  F Coceani; P M Olley; J E Lock
Journal:  Eur J Clin Pharmacol       Date:  1980-07       Impact factor: 2.953

Review 6.  Comparative tolerability of pharmacological treatments for patent ductus arteriosus.

Authors:  C Hammerman; M Kaplan
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.